Product Information
SERTRALINE HCL 50 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0343 per EA under NDC 31722014690. Its NADAC has been published 184 times since Dec 21, 2022.
Strength
50 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722014690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SERTRALINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214790On Market Since
5/3/2021
Pharmacological Classes
Price Statistics
The NADAC for SERTRALINE HCL 50 MG TABLET has been published 184 times since Dec 21, 2022, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0343 per EA |
|---|---|
| All-time high | $0.0459 (Aug 16, 2023) |
| All-time low | $0.0292 (Nov 20, 2024) |
| 52-week high | $0.0388 |
| 52-week low | $0.0343 |
| Median price | $0.0385 |
| Average price | $0.0383 |
| Largest weekly change | -26.1% (Nov 20, 2024) |
| Weeks tracked | 184 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SERTRALINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE HCL 50 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0343 per EA (NDC 31722014690), effective Jun 24, 2026.
How has the price of SERTRALINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SERTRALINE HCL 50 MG TABLET has declined 15.1%. It has been tracked across 184 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for SERTRALINE HCL 50 MG TABLET?
Since Dec 21, 2022, the NADAC for SERTRALINE HCL 50 MG TABLET has ranged from a low of $0.0292 (Nov 20, 2024) to a high of $0.0459 (Aug 16, 2023), with a median of $0.0385 per EA.
Are there cheaper alternatives to SERTRALINE HCL 50 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as SERTRALINE HCL 50 MG TABLET, but none are currently priced below it.
Who manufactures SERTRALINE HCL 50 MG TABLET?
SERTRALINE HCL 50 MG TABLET (NDC 31722014690) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification